article thumbnail

PCI for stable angina : Sham trials are welcome, but not OMT shaming trials !

Dr. S. Venkatesan MD

After a series of experiments in animals and peripheral vessels, he proved with a single patient N-1 study that effectively treated refractory LAD angina in a 38-year-old man in 1977. No one has questioned the efficacy of PCI for true angina with a critical lesion. ORBITA-2 came in 2023. 2023 Dec 21;389(25):2319-2330.

Angina 52
article thumbnail

ORBITA 2: The power of PCI revealed for stable angina

Cardiology Update

The ORBITA-2 trial ( NCT03742050 ) investigated the efficacy of Percutaneous Coronary Intervention (PCI) compared to placebo in 301 patients with stable angina. At the 12-week mark, the PCI group exhibited a significantly lower mean angina score (2.9) 2023;Epub ahead of print. 2023;Epub ahead of print. 3.47; p<0.001).

Angina 52
article thumbnail

Efficacy and safety of tongxinluo capsule for angina pectoris of coronary heart disease: an overview of systematic reviews and meta-analysis

Frontiers in Cardiovascular Medicine

Background Tongxinluo capsule (TXLC) is a common drug for treating angina pectoris of coronary heart disease (CHD). In recent years, many systematic reviews (SRs) and meta-analyses (MAs) have reported the efficacy and safety of TXLC for improving angina symptoms in patients with CHD.

Angina 64
article thumbnail

Prospective cohort study for evaluating the safety and efficacy of mobile, motorized enhanced extracorporeal counterpulsation in refractory angina patients

The American Journal of Cardiology

Publication date: Available online 16 December 2023 Source: The American Journal of Cardiology Author(s): Jooyeon Lee, Jaewon Oh, In-Cheol Kim, Seonhwa Lee, Se-Eun Kim, Chan Joo Lee, Hyungseop Kim, Seok-Min Kang

Angina 52
article thumbnail

Decoding the Menace Within: Unraveling Myocardial Bridges and Exercise-Induced Ischemia

Cardiology Update

The perplexing landscape of angina with nonobstructive coronary arteries (ANOCA) encompasses diverse pathophysiological entities, including coronary microvascular disease (CMD), coronary artery spasm, and the enigmatic myocardial bridging (MB). Original article: Sinha A et al. Circ Cardiovasc Interv.

Exercise 119
article thumbnail

Long-term outcomes of ischaemia with no obstructive coronary artery disease (INOCA): a systematic review and meta-analysis

Open Heart

Background The prognosis of myocardial ischaemia with no obstructive coronary artery disease (INOCA) and its underlying vasomotor disorders, vasospastic angina (VSA) and microvascular angina (MVA), is not well defined.

article thumbnail

Do Stents Make You Feel Better?

Dr. Paddy Barrett

Whether stenting a narrowed coronary artery improves symptoms such as chest pain (angina) or shortness of breath is a very different question. Share Angina The classic definition of angina involves the sensation of tightness in the centre of the chest that is brought on with exertion and is relieved with rest. The result?

Stent 59